ArticleJournal of clinical medicine2024

Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness.

Kumiko Hirayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.